Molecular genetic analysis is an integral part of colorectal cancer (CRC) management. The
choice of systemic therapy for CRC is largely based on the results of tumor molecular testing. …

Colorectal cancer (CRC) is a heterogeneous disease, arising from many possible etiological
pathways. This heterogeneity can have important implications for CRC prognosis and …

Despite recent advances in detection and treatment, colorectal cancer (CRC) represents a
major global public health problem. In Korea, the incidence of CRC has been rapidly …

… This article condenses the available scientific evidence into useful information about
commonly asked clinical questions about colorectal cancer screening. CLINICAL QUESTIONS …

… for clinical applications, such as gut microbiota analysis as screening, prognostic or predictive
biomarkers, or modulating microorganisms to prevent cancer, … in colorectal neoplasia, …

… in colorectal cancer we set this study to quantitative candidate genes expression in colorectal
cancer … in tumour and tumour-associated normal colorectal tissue. In addition, we aimed to …

… Finally, we will discuss the necessary steps prior to development of a clinical application of
… dissection of various types of human cancers, including colorectal cancer (CRC). This review …

… In this review, we first highlight clinical applications of DNA methylation biomarkers that
have the greatest potential for improving diagnosis, prognosis and prediction of treatment …

… clinical applications of predominantly microarray-based assays in colorectal cancer. There
are many promising applications which will support early detection and targeted therapies in …

… the clinical needs outlined above. This review aims to provide an overview of colon cancer
… biomarker proteins that carry potential for a clinical application. Since the field was already …